Related Experiment Video
Updated: Feb 13, 2026

Reprograming Model of Human Monocyte-derived Macrophages for In-vitro Assays
Published on: April 18, 2025
Macrophage-Derived Protein S Facilitates Apoptotic Polymorphonuclear Cell Clearance by Resolution Phase Macrophages
Delphine Lumbroso1,2, Soaad Soboh1, Avi Maimon2
1Faculty of Dental Medicine, Institute for Dental Sciences, Hadassah Medical School, Hebrew University of Jerusalem, Jerusalem, Israel.
Abstract:
The complete resolution of inflammation requires the uptake of apoptotic polymorphonuclear cells (PMN) by local macrophages (efferocytosis) and the consequent reprogramming of the engulfing phagocytes to reparative and pro-resolving phenotypes. The tyrosine kinase receptors TYRO3, AXL, and MERTK (collectively named TAM) are fundamental mediators in regulating inflammatory responses and efferocytosis. Protein S (PROS1) is a ligand for all TAM receptors that mediates various aspects of their activity. However, the involvement of PROS1 in the resolution of inflammation is incompletely understood. Here, we report the upregulation of Pros1 in macrophages during the resolution of inflammation. Selective knockout of Pros1 in the myeloid lineage significantly downregulated macrophage pro-resolving properties. Hence, Pros1-deficient macrophages engulfed fewer apoptotic PMN remnants in vivo, and exogenous PROS1 rescued impaired efferocytosis ex vivo. Moreover, Pros1-deficient peritoneal macrophages secreted higher levels of the pro-inflammatory mediators TNFα and CCL3, while they secreted lower levels of the reparative/anti-inflammatory IL-10 following exposure to lipopolysaccharide in comparison to their WT counterparts. Moreover, Pros1-deficient macrophages expressed less of the anti-inflammatory/pro-resolving enzymes arginase-1 and 12/15-lipoxygenase and produced less of the specialized pro-resolving mediator resolvin D1. Altogether, our results suggest that macrophage-derived PROS1 is an important effector molecule in regulating the efferocytosis, maturation, and reprogramming of resolution phase macrophages, and imply that PROS1 could provide a new therapeutic target for inflammatory and fibrotic disorders.
Insights
Protein S (PROS1) is crucial for macrophage efferocytosis and reprogramming during inflammation resolution. Macrophage-specific PROS1 deficiency impairs efferocytosis and promotes pro-inflammatory responses, highlighting PROS1 as a therapeutic target.
Area of Science:
- Immunology
- Molecular Biology
- Cell Biology
Background:
- Inflammation resolution requires macrophages to engulf apoptotic cells (efferocytosis) and adopt reparative phenotypes.
- Tyrosine kinase receptors TYRO3, AXL, and MERTK (TAM) regulate inflammation and efferocytosis.
- Protein S (PROS1) is a TAM receptor ligand, but its role in inflammation resolution is unclear.
Purpose of the Study:
- To investigate the role of Protein S (PROS1) in macrophage efferocytosis and reprogramming during inflammation resolution.
- To determine if macrophage-derived PROS1 influences the resolution phase of inflammation.
Main Methods:
- Upregulation of Pros1 in macrophages during inflammation resolution was assessed.
- Selective knockout of Pros1 in myeloid cells was performed to evaluate its function.
- Efferocytosis of apoptotic polymorphonuclear cells (PMN) by Pros1-deficient macrophages was measured in vivo and ex vivo.
- Macrophage secretion of inflammatory and anti-inflammatory mediators, as well as pro-resolving enzymes and lipid mediators, was analyzed.
Main Results:
- Pros1 was upregulated in macrophages during inflammation resolution.
- Myeloid-specific knockout of Pros1 impaired efferocytosis of apoptotic PMN.
- Pros1-deficient macrophages exhibited reduced pro-resolving properties, including lower IL-10, arginase-1, 12/15-lipoxygenase, and resolvin D1 production.
- Conversely, Pros1-deficient macrophages secreted higher levels of pro-inflammatory mediators TNFα and CCL3.
Conclusions:
- Macrophage-derived PROS1 is essential for efficient efferocytosis and reprogramming of macrophages towards a pro-resolving phenotype.
- PROS1 plays a critical role in the resolution phase of inflammation.
- PROS1 represents a potential therapeutic target for inflammatory and fibrotic disorders.
Related Concept Videos
Facilitated Transport
Facilitated Transport
Phagocytosis of Apoptotic Cells
Normal cells contain receptors that prevent them from being recognized...
Hepatic Drug Clearance: Effect of Protein Binding
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
Social Facilitation
Somatic to iPS Cell Reprogramming

